1. |
Gass JD. Uveal effusion syndrome: a new hypothesis concerning pathogenesis and technique of surgical treatment[J]. Trans Am Ophthalmol Soc, 1983, 81: 246-260.
|
2. |
Uyama M, Takahashi K, Kozaki J, et al. Uveal effusion syndrome: clinical features, surgical treatment, histologic examination of the sclera, and pathophysiology[J]. Ophthalmology, 2000, 107(3): 441-449. DOI: 10.1016/s0161-6420(99)00141-4.
|
3. |
张承芬. 葡萄膜渗漏[M]//张承芬. 眼底病学. 2版. 北京: 人民卫生出版社, 2017: 492-495.Zhang CF. Uveal effusion[M]//Zhang CF. Diseases of ocular fundus. 2nd ed. Beijing: People’s Medical Publishing House, 2017: 492-495.
|
4. |
Ikeda N, Ikeda T, Nomura C, et al. Ciliochoroidal effusion syndrome associated with posterior scleritis[J]. Jpn J Ophthalmol, 2007, 51(1): 49-52. DOI: 10.1007/s10384-006-0398-x.
|
5. |
Terubayashi Y, Morishita S, Kohmoto R, et al. Type Ⅲ uveal effusion syndrome suspected to be related to pachychoroid spectrum disease: a case report[J/OL]. Medicine (Baltimore), 2020, 99(31): e21441[2020-07-31]. https://pubmed.ncbi.nlm.nih.gov/32756157/. DOI: 10.1097/MD.0000000000021441.
|
6. |
Anwar M, Brockmann T, Walckling M, et al. Acute angle-closure glaucoma and effusion syndrome after phacoemulsification[J]. Ophthalmologe, 2021, 118(8): 838-841. DOI: 10.1007/s00347-020-01202-6.
|
7. |
Chen C, Wang S, Zhang G, et al. Uveal effusion syndrome as the initial manifestation of primary Sjögren's syndrome and review of the literature[J]. Ocul Immunol Inflamm, 2021, 29(7-8): 1348-1354. DOI: 10.1080/09273948.2020.1748202.
|
8. |
Piñeiro Ces A, Bande Rodriguez M, Rodriguez Blanco M, et al. Very high-frequency ultrasonography signs in bilateral acute choroidal effusion associated with systemic sulphonamide medications: 2 cases[J]. Case Rep Ophthalmol, 2022, 13(1): 64-69. DOI: 10.1159/000516860.
|
9. |
Lan YW, Hsieh JW. Bilateral acute angle closure glaucoma and myopic shift by topiramate-induced ciliochoroidal effusion: case report and literature review[J]. Int Ophthalmol, 2018, 38(6): 2639-2648. DOI: 10.1007/s10792-017-0740-y.
|
10. |
Végh M, Hári-Kovács A, Réz K, et al. Indapamide-induced transient myopia with supraciliary effusion: case report[J]. BMC Ophthalmol, 2013, 13: 58. DOI: 10.1186/1471-2415-13-58. DOI: 10.1186/1471-2415-13-58.
|
11. |
Phylactou M, Matarazzo F, Jones E, et al. Indapamide-induced bilateral choroidal effusion in pseudophakic patient[J/OL]. BMJ Case Rep, 2018, 2018: bcr2018225920[2018-07-26]. https://pubmed.ncbi.nlm.nih.gov/30054327/. DOI: 10.1136/bcr-2018-225920.
|
12. |
Takahashi S, Usui S, Hashida N, et al. Multimodal imaging of indapamide-induced bilateral choroidal effusion: a case report[J]. BMC Ophthalmol, 2021, 21(1): 386. DOI: 10.1186/s12886-021-02147-3.
|
13. |
Blain P, Paques M, Massin P, et al. Acute transient myopia induced by indapamide[J]. Am J Ophthalmol, 2000, 129(4): 538-540. DOI: 10.1016/s0002-9394(99)00402-x. DOI: 10.1016/S0002-9394(99)00402-X.
|
14. |
祁媛媛, 王红, 曹绪胜, 等. 葡萄膜渗漏综合征临床特征及巩膜切除手术疗效观察[J]. 中华眼底病杂志, 2019, 35(4): 374-377. DOI: 10.3760/cma.j.issn.1005-1015.2019.04.012.Qi YY, Wang H, Cao XS, et al. Clinical features of uveal effusion syndrome and the efficacy of sclerectomy in the treatment of uveal effusion syndrome[J]. Chin J Ocul Fundus Dis, 2019, 35(4): 374-377. DOI: 10.3760/cma.j.issn.1005-1015.2019.04.012.
|
15. |
Claeys E, Stalmans P, Van Calster J, et al. A retrospective case series of uveal effusion syndrome[J]. J Glaucoma, 2020, 29(10): 995-998. DOI: 10.1097/IJG.0000000000001606.
|